We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market...
PROVIDENCE, Rhode Island, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on October 16, 2024, it received a Staff Determination Letter from The...
Ocean Biomedicalβs Anti-CHI3L1 patent coverage includes multiple methods of use for targeting a broad range of Cancers that include Lung Cancer, Glioblastoma, Prostate Cancer, Melanoma, and Breast...
Providence, RI, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that its Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been issued a key U.S. patent...
PROVIDENCE, Rhode Island, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on August 19, 2024, it received a notice from The Nasdaq Stock Market LLC...
Providence, RI, June 05, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ:Β OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...
PROVIDENCE, Rhode Island, May 30, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc.Β (NASDAQ:Β OCEA), today announced that on May 22, 2024, it received a notice fromΒ The Nasdaq Stock Market...
Providence, RI, May 16, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been granted a new patent for his...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.027 | -4.65517241379 | 0.58 | 0.6072 | 0.5329 | 182479 | 0.57191161 | CS |
4 | -0.147 | -21 | 0.7 | 0.72 | 0.4603 | 606373 | 0.65562474 | CS |
12 | -0.397 | -41.7894736842 | 0.95 | 1.16 | 0.4603 | 228984 | 0.69683864 | CS |
26 | -0.627 | -53.1355932203 | 1.18 | 1.45 | 0.4603 | 139251 | 0.79977067 | CS |
52 | -0.095 | -14.6604938272 | 0.648 | 7.79 | 0.4603 | 1820995 | 2.92823358 | CS |
156 | -9.407 | -94.4477911647 | 9.96 | 26.5986 | 0.4603 | 1579574 | 4.68117727 | CS |
260 | -9.407 | -94.4477911647 | 9.96 | 26.5986 | 0.4603 | 1579574 | 4.68117727 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions